Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Optom Vis Sci. 2017 Dec;94(12):1095–1101. doi: 10.1097/OPX.0000000000001139

Table 2.

Percentage and Number of Visits Where the Communication Variables Were Discussed (N=275).

Communication Variable Percent (N) of Visits Where Variable was Discussed
Overall Medication and Other Cost Discussion
Medication Cost Discussed During the Baseline Visit 31.6 (87)
Patient Indicates that Cost is a Problem during the Baseline Visit 4.7 (13)
Provider Behavior
Physician Asks About a Glaucoma Medication Cost Problem 1.4 (4)
Physician Proposes a Solution to a Potential Glaucoma-Related Cost Problem 17.9 (50)
Physician Recommends Patient Work with Pharmacist to Lower Glaucoma Medication Cost 1.1 (3)
Physician Asks How Much Patient is Paying for Glaucoma Medications 2.2 (6)
Physician Recommends Patient Try a 3-Month Supply of Glaucoma Medications to Reduce Cost 2.2 (6)
Patient Behavior
Patient had Changed Glaucoma Medication Regimen Due to Cost Problem 6.1 (17)
Patient Discusses Coping Strategies Used in the Past to Deal with Cost Problem 1.8 (5)
Insurance and Drug Cost
Patients Health Insurance or Prescription Drug Coverage is Discussed 14.7 (41)
Coinsurance or Copayment is Discussed 11.1 (31)
Medication Assistance Programs are Discussed 2.2 (6)
Four Dollar Generics are Discussed 2.5 (7)
Laser is Discussed as a Solution to a Medication Cost Problem 0.4 (1)
Samples
Patient Requests Samples 0.0 (0)
Physician Provides Samples 6.5 (18)
Physician Discusses Being Unable to Provide Samples 0.7 (2)
Medication Discussion
Term Brand or Generic is Used 19.0 (53)
Physician Initiates Discussion of Brand or Generic 14.7 (41)
Physician Explains Difference Between Brand and Generic 0.7 (2)
Patient Expresses Confusion Concerning Brand versus Generic 0.7 (2)
Physician Says Generic isn’t Available 3.2 (9)
Physician Offers to Write a Prescription for Generic 8.6 (24)
Physician Asks if Patient has a Preference for Generic or Brand 3.6 (10)
Patient Expresses Preference for Generic 6.1 (17)
Patient Expresses Preference for Brand 1.8 (5)